Singapore, Singapore

Sandy Wen-Hsin Lee

This inventor holds 1 USPTO granted patent. Top assignee: Agency for Science, Technology and Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandy Wen-Hsin Lee. Retrieved from https://idiyas.com/inventor/sandy-wen-hsin-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandy Wen-Hsin Lee: Innovator in Anti-HER2 Antibodies

Introduction

Sandy Wen-Hsin Lee is a prominent inventor based in Singapore, known for her significant contributions to the field of biotechnology. She has developed innovative solutions that have the potential to impact therapeutic applications significantly.

Latest Patents

Sandy holds a patent for Anti-HER2 antibodies. This patent includes antibodies, antigen-binding fragments, and polypeptides that bind to HER2. It also encompasses nucleic acids and vectors encoding these molecules. Furthermore, the patent details methods of making such molecules and their use for therapeutic applications.

Career Highlights

Sandy is affiliated with the Agency for Science, Technology and Research, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the biotechnology sector.

Collaborations

Sandy has collaborated with notable colleagues, including Cheng-I Wang and Lionel Jianrong Low, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Sandy Wen-Hsin Lee's innovative work in developing Anti-HER2 antibodies showcases her dedication to advancing medical science. Her contributions are poised to make a lasting impact in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…